nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—stomach cancer	0.792	1	CbGaD
Nepafenac—Lacrimation—Floxuridine—stomach cancer	0.00794	0.0635	CcSEcCtD
Nepafenac—Lacrimation increased—Floxuridine—stomach cancer	0.00507	0.0405	CcSEcCtD
Nepafenac—Scab—Fluorouracil—stomach cancer	0.00479	0.0383	CcSEcCtD
Nepafenac—Photophobia—Floxuridine—stomach cancer	0.00438	0.0351	CcSEcCtD
Nepafenac—Punctate keratitis—Capecitabine—stomach cancer	0.00422	0.0337	CcSEcCtD
Nepafenac—Ocular discomfort—Methotrexate—stomach cancer	0.00349	0.0279	CcSEcCtD
Nepafenac—Scab—Capecitabine—stomach cancer	0.00335	0.0268	CcSEcCtD
Nepafenac—Lacrimation—Irinotecan—stomach cancer	0.00271	0.0216	CcSEcCtD
Nepafenac—Lacrimation—Fluorouracil—stomach cancer	0.00259	0.0207	CcSEcCtD
Nepafenac—Blepharitis—Fluorouracil—stomach cancer	0.00248	0.0198	CcSEcCtD
Nepafenac—Mefenamic acid—AKR1C3—stomach cancer	0.00197	0.184	CrCbGaD
Nepafenac—Lacrimation—Docetaxel—stomach cancer	0.00187	0.015	CcSEcCtD
Nepafenac—Impaired healing—Methotrexate—stomach cancer	0.00183	0.0147	CcSEcCtD
Nepafenac—Visual acuity reduced—Capecitabine—stomach cancer	0.00179	0.0143	CcSEcCtD
Nepafenac—Eye irritation—Fluorouracil—stomach cancer	0.00179	0.0143	CcSEcCtD
Nepafenac—Lacrimation increased—Irinotecan—stomach cancer	0.00173	0.0138	CcSEcCtD
Nepafenac—Lacrimation increased—Fluorouracil—stomach cancer	0.00165	0.0132	CcSEcCtD
Nepafenac—Keratitis—Capecitabine—stomach cancer	0.00164	0.0131	CcSEcCtD
Nepafenac—Nervous system disorder—Floxuridine—stomach cancer	0.00163	0.0131	CcSEcCtD
Nepafenac—Vision blurred—Mitomycin—stomach cancer	0.00151	0.0121	CcSEcCtD
Nepafenac—Dermatitis atopic—Docetaxel—stomach cancer	0.00149	0.0119	CcSEcCtD
Nepafenac—Photophobia—Fluorouracil—stomach cancer	0.00143	0.0114	CcSEcCtD
Nepafenac—Hypertension—Mitomycin—stomach cancer	0.00138	0.0111	CcSEcCtD
Nepafenac—Eye irritation—Docetaxel—stomach cancer	0.00129	0.0103	CcSEcCtD
Nepafenac—Lacrimation—Epirubicin—stomach cancer	0.00126	0.0101	CcSEcCtD
Nepafenac—Eye irritation—Capecitabine—stomach cancer	0.00125	0.00997	CcSEcCtD
Nepafenac—Hypersensitivity—Floxuridine—stomach cancer	0.00123	0.00981	CcSEcCtD
Nepafenac—Lacrimation increased—Docetaxel—stomach cancer	0.00119	0.00954	CcSEcCtD
Nepafenac—Lacrimation—Doxorubicin—stomach cancer	0.00117	0.00934	CcSEcCtD
Nepafenac—Lacrimation increased—Capecitabine—stomach cancer	0.00116	0.00924	CcSEcCtD
Nepafenac—Keratitis—Epirubicin—stomach cancer	0.00114	0.00915	CcSEcCtD
Nepafenac—Cataract—Capecitabine—stomach cancer	0.00112	0.00895	CcSEcCtD
Nepafenac—Blood pressure increased—Docetaxel—stomach cancer	0.0011	0.0088	CcSEcCtD
Nepafenac—PTGS1—blood vessel—stomach cancer	0.0011	0.113	CbGeAlD
Nepafenac—Blood pressure increased—Capecitabine—stomach cancer	0.00107	0.00852	CcSEcCtD
Nepafenac—Vomiting—Floxuridine—stomach cancer	0.00106	0.00847	CcSEcCtD
Nepafenac—Keratitis—Doxorubicin—stomach cancer	0.00106	0.00846	CcSEcCtD
Nepafenac—PTGS2—blood vessel—stomach cancer	0.00105	0.108	CbGeAlD
Nepafenac—Headache—Floxuridine—stomach cancer	0.00104	0.00834	CcSEcCtD
Nepafenac—Diclofenac—ALOX5—stomach cancer	0.00103	0.0958	CrCbGaD
Nepafenac—Dermatitis atopic—Epirubicin—stomach cancer	0.001	0.00802	CcSEcCtD
Nepafenac—Nausea—Floxuridine—stomach cancer	0.00099	0.00791	CcSEcCtD
Nepafenac—PTGS2—gall bladder—stomach cancer	0.000985	0.101	CbGeAlD
Nepafenac—Dry eye—Capecitabine—stomach cancer	0.000984	0.00787	CcSEcCtD
Nepafenac—Dermatitis atopic—Doxorubicin—stomach cancer	0.000928	0.00742	CcSEcCtD
Nepafenac—Diabetes mellitus—Capecitabine—stomach cancer	0.000889	0.00711	CcSEcCtD
Nepafenac—Dizziness—Mitomycin—stomach cancer	0.000865	0.00691	CcSEcCtD
Nepafenac—Eye pain—Capecitabine—stomach cancer	0.000857	0.00685	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—stomach cancer	0.000849	0.0793	CrCbGaD
Nepafenac—Vomiting—Mitomycin—stomach cancer	0.000831	0.00665	CcSEcCtD
Nepafenac—Headache—Mitomycin—stomach cancer	0.000819	0.00655	CcSEcCtD
Nepafenac—Lacrimation increased—Epirubicin—stomach cancer	0.000805	0.00644	CcSEcCtD
Nepafenac—Sinusitis—Fluorouracil—stomach cancer	0.0008	0.0064	CcSEcCtD
Nepafenac—Arthritis—Capecitabine—stomach cancer	0.000796	0.00636	CcSEcCtD
Nepafenac—Nausea—Mitomycin—stomach cancer	0.000777	0.00621	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—stomach cancer	0.000752	0.0703	CrCbGaD
Nepafenac—Lacrimation increased—Doxorubicin—stomach cancer	0.000745	0.00596	CcSEcCtD
Nepafenac—Angiopathy—Irinotecan—stomach cancer	0.000725	0.0058	CcSEcCtD
Nepafenac—Immune system disorder—Irinotecan—stomach cancer	0.000722	0.00577	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—stomach cancer	0.000698	0.0652	CrCbGaD
Nepafenac—Dry eye—Epirubicin—stomach cancer	0.000685	0.00548	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—stomach cancer	0.000669	0.0625	CrCbGaD
Nepafenac—Diabetes mellitus—Methotrexate—stomach cancer	0.000662	0.00529	CcSEcCtD
Nepafenac—Dry eye—Doxorubicin—stomach cancer	0.000634	0.00507	CcSEcCtD
Nepafenac—Vision blurred—Fluorouracil—stomach cancer	0.000628	0.00502	CcSEcCtD
Nepafenac—Diabetes mellitus—Epirubicin—stomach cancer	0.000619	0.00495	CcSEcCtD
Nepafenac—Hypertension—Irinotecan—stomach cancer	0.000601	0.0048	CcSEcCtD
Nepafenac—Eye pain—Epirubicin—stomach cancer	0.000597	0.00477	CcSEcCtD
Nepafenac—PTGS1—hematopoietic system—stomach cancer	0.000583	0.0601	CbGeAlD
Nepafenac—Diabetes mellitus—Doxorubicin—stomach cancer	0.000573	0.00458	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—stomach cancer	0.000569	0.0532	CrCbGaD
Nepafenac—PTGS2—hematopoietic system—stomach cancer	0.000557	0.0574	CbGeAlD
Nepafenac—Nervous system disorder—Irinotecan—stomach cancer	0.000557	0.00445	CcSEcCtD
Nepafenac—Eye pain—Doxorubicin—stomach cancer	0.000552	0.00441	CcSEcCtD
Nepafenac—Nervous system disorder—Fluorouracil—stomach cancer	0.000533	0.00426	CcSEcCtD
Nepafenac—PTGS1—epithelium—stomach cancer	0.000533	0.0549	CbGeAlD
Nepafenac—Magnesium salicylate—PTGS2—stomach cancer	0.000529	0.0494	CrCbGaD
Nepafenac—Fenbufen—PTGS2—stomach cancer	0.000518	0.0484	CrCbGaD
Nepafenac—Eye disorder—Docetaxel—stomach cancer	0.000516	0.00413	CcSEcCtD
Nepafenac—PTGS1—smooth muscle tissue—stomach cancer	0.000514	0.0529	CbGeAlD
Nepafenac—PTGS2—epithelium—stomach cancer	0.00051	0.0525	CbGeAlD
Nepafenac—Angiopathy—Docetaxel—stomach cancer	0.000501	0.00401	CcSEcCtD
Nepafenac—Eye disorder—Capecitabine—stomach cancer	0.0005	0.004	CcSEcCtD
Nepafenac—Immune system disorder—Docetaxel—stomach cancer	0.000499	0.00399	CcSEcCtD
Nepafenac—PTGS2—smooth muscle tissue—stomach cancer	0.000491	0.0506	CbGeAlD
Nepafenac—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00049	0.00392	CcSEcCtD
Nepafenac—Angiopathy—Capecitabine—stomach cancer	0.000485	0.00388	CcSEcCtD
Nepafenac—Immune system disorder—Capecitabine—stomach cancer	0.000483	0.00386	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—stomach cancer	0.000471	0.044	CrCbGaD
Nepafenac—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00047	0.00375	CcSEcCtD
Nepafenac—PTGS2—pancreas—stomach cancer	0.000454	0.0467	CbGeAlD
Nepafenac—Salsalate—PTGS2—stomach cancer	0.00045	0.042	CrCbGaD
Nepafenac—Vision blurred—Capecitabine—stomach cancer	0.000439	0.00351	CcSEcCtD
Nepafenac—Hypersensitivity—Irinotecan—stomach cancer	0.000418	0.00334	CcSEcCtD
Nepafenac—Hypertension—Docetaxel—stomach cancer	0.000415	0.00332	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000407	0.00325	CcSEcCtD
Nepafenac—PTGS1—digestive system—stomach cancer	0.000406	0.0418	CbGeAlD
Nepafenac—Hypertension—Capecitabine—stomach cancer	0.000402	0.00321	CcSEcCtD
Nepafenac—Hypersensitivity—Fluorouracil—stomach cancer	0.000401	0.0032	CcSEcCtD
Nepafenac—Dry mouth—Docetaxel—stomach cancer	0.0004	0.0032	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000394	0.00315	CcSEcCtD
Nepafenac—PTGS2—lymphoid tissue—stomach cancer	0.000392	0.0404	CbGeAlD
Nepafenac—Sinusitis—Epirubicin—stomach cancer	0.000389	0.00311	CcSEcCtD
Nepafenac—Dry mouth—Capecitabine—stomach cancer	0.000388	0.0031	CcSEcCtD
Nepafenac—PTGS2—digestive system—stomach cancer	0.000388	0.0399	CbGeAlD
Nepafenac—Nervous system disorder—Docetaxel—stomach cancer	0.000385	0.00308	CcSEcCtD
Nepafenac—Pruritus—Fluorouracil—stomach cancer	0.000385	0.00308	CcSEcCtD
Nepafenac—Skin disorder—Docetaxel—stomach cancer	0.000381	0.00305	CcSEcCtD
Nepafenac—Dizziness—Irinotecan—stomach cancer	0.000375	0.003	CcSEcCtD
Nepafenac—Nervous system disorder—Capecitabine—stomach cancer	0.000373	0.00298	CcSEcCtD
Nepafenac—Eye disorder—Methotrexate—stomach cancer	0.000372	0.00298	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—stomach cancer	0.000372	0.0347	CrCbGaD
Nepafenac—Skin disorder—Capecitabine—stomach cancer	0.000369	0.00295	CcSEcCtD
Nepafenac—Angiopathy—Methotrexate—stomach cancer	0.000361	0.00289	CcSEcCtD
Nepafenac—Vomiting—Irinotecan—stomach cancer	0.000361	0.00289	CcSEcCtD
Nepafenac—Sinusitis—Doxorubicin—stomach cancer	0.00036	0.00288	CcSEcCtD
Nepafenac—Immune system disorder—Methotrexate—stomach cancer	0.00036	0.00288	CcSEcCtD
Nepafenac—Dizziness—Fluorouracil—stomach cancer	0.00036	0.00288	CcSEcCtD
Nepafenac—PTGS2—bone marrow—stomach cancer	0.000357	0.0368	CbGeAlD
Nepafenac—Headache—Irinotecan—stomach cancer	0.000356	0.00284	CcSEcCtD
Nepafenac—Eye disorder—Epirubicin—stomach cancer	0.000348	0.00278	CcSEcCtD
Nepafenac—Vomiting—Fluorouracil—stomach cancer	0.000346	0.00276	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—stomach cancer	0.000345	0.0322	CrCbGaD
Nepafenac—Headache—Fluorouracil—stomach cancer	0.000341	0.00272	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000339	0.00271	CcSEcCtD
Nepafenac—Angiopathy—Epirubicin—stomach cancer	0.000338	0.0027	CcSEcCtD
Nepafenac—Nausea—Irinotecan—stomach cancer	0.000337	0.0027	CcSEcCtD
Nepafenac—Immune system disorder—Epirubicin—stomach cancer	0.000337	0.00269	CcSEcCtD
Nepafenac—PTGS1—endocrine gland—stomach cancer	0.000335	0.0345	CbGeAlD
Nepafenac—Fenoprofen—ALB—stomach cancer	0.000331	0.0309	CrCbGaD
Nepafenac—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000328	0.00262	CcSEcCtD
Nepafenac—Vision blurred—Methotrexate—stomach cancer	0.000327	0.00261	CcSEcCtD
Nepafenac—Nausea—Fluorouracil—stomach cancer	0.000323	0.00258	CcSEcCtD
Nepafenac—Eye disorder—Doxorubicin—stomach cancer	0.000322	0.00258	CcSEcCtD
Nepafenac—PTGS2—endocrine gland—stomach cancer	0.00032	0.033	CbGeAlD
Nepafenac—Angiopathy—Doxorubicin—stomach cancer	0.000313	0.0025	CcSEcCtD
Nepafenac—Immune system disorder—Doxorubicin—stomach cancer	0.000311	0.00249	CcSEcCtD
Nepafenac—Vision blurred—Epirubicin—stomach cancer	0.000306	0.00244	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000293	0.00234	CcSEcCtD
Nepafenac—Hypersensitivity—Docetaxel—stomach cancer	0.000289	0.00231	CcSEcCtD
Nepafenac—PTGS2—liver—stomach cancer	0.000289	0.0297	CbGeAlD
Nepafenac—Vision blurred—Doxorubicin—stomach cancer	0.000283	0.00226	CcSEcCtD
Nepafenac—Hypertension—Epirubicin—stomach cancer	0.00028	0.00224	CcSEcCtD
Nepafenac—Hypersensitivity—Capecitabine—stomach cancer	0.00028	0.00224	CcSEcCtD
Nepafenac—Oxcarbazepine—ALB—stomach cancer	0.000278	0.0259	CrCbGaD
Nepafenac—Pruritus—Docetaxel—stomach cancer	0.000278	0.00222	CcSEcCtD
Nepafenac—Nervous system disorder—Methotrexate—stomach cancer	0.000277	0.00222	CcSEcCtD
Nepafenac—Skin disorder—Methotrexate—stomach cancer	0.000275	0.0022	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000274	0.00219	CcSEcCtD
Nepafenac—Dry mouth—Epirubicin—stomach cancer	0.00027	0.00216	CcSEcCtD
Nepafenac—Pruritus—Capecitabine—stomach cancer	0.000269	0.00215	CcSEcCtD
Nepafenac—Nervous system disorder—Epirubicin—stomach cancer	0.00026	0.00208	CcSEcCtD
Nepafenac—Dizziness—Docetaxel—stomach cancer	0.00026	0.00208	CcSEcCtD
Nepafenac—Hypertension—Doxorubicin—stomach cancer	0.000259	0.00207	CcSEcCtD
Nepafenac—Skin disorder—Epirubicin—stomach cancer	0.000257	0.00206	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000254	0.00203	CcSEcCtD
Nepafenac—Dizziness—Capecitabine—stomach cancer	0.000251	0.00201	CcSEcCtD
Nepafenac—Dry mouth—Doxorubicin—stomach cancer	0.00025	0.002	CcSEcCtD
Nepafenac—Vomiting—Docetaxel—stomach cancer	0.00025	0.002	CcSEcCtD
Nepafenac—Diclofenac—PTGS2—stomach cancer	0.000248	0.0231	CrCbGaD
Nepafenac—Headache—Docetaxel—stomach cancer	0.000246	0.00197	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000244	0.00195	CcSEcCtD
Nepafenac—Vomiting—Capecitabine—stomach cancer	0.000242	0.00193	CcSEcCtD
Nepafenac—Nervous system disorder—Doxorubicin—stomach cancer	0.00024	0.00192	CcSEcCtD
Nepafenac—Headache—Capecitabine—stomach cancer	0.000238	0.0019	CcSEcCtD
Nepafenac—Skin disorder—Doxorubicin—stomach cancer	0.000238	0.0019	CcSEcCtD
Nepafenac—Nausea—Docetaxel—stomach cancer	0.000233	0.00186	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—SOD2—stomach cancer	0.000232	0.00373	CbGpPWpGaD
Nepafenac—PTGS1—lymph node—stomach cancer	0.000232	0.0239	CbGeAlD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000231	0.00371	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.00023	0.0037	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000229	0.00183	CcSEcCtD
Nepafenac—Nausea—Capecitabine—stomach cancer	0.000226	0.0018	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—APEX1—stomach cancer	0.000223	0.00358	CbGpPWpGaD
Nepafenac—PTGS2—lymph node—stomach cancer	0.000221	0.0228	CbGeAlD
Nepafenac—Diclofenac—ALB—stomach cancer	0.000221	0.0206	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—stomach cancer	0.000219	0.0205	CrCbGaD
Nepafenac—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000211	0.00169	CcSEcCtD
Nepafenac—Hypersensitivity—Methotrexate—stomach cancer	0.000208	0.00167	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.000207	0.00333	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—stomach cancer	0.000206	0.00332	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—MTHFR—stomach cancer	0.000204	0.00329	CbGpPWpGaD
Nepafenac—Pruritus—Methotrexate—stomach cancer	0.0002	0.0016	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.0002	0.00322	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—stomach cancer	0.000199	0.00319	CbGpPWpGaD
Nepafenac—Ketoprofen—ALB—stomach cancer	0.000196	0.0183	CrCbGaD
Nepafenac—Hypersensitivity—Epirubicin—stomach cancer	0.000195	0.00156	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000193	0.00311	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—BDNF—stomach cancer	0.000191	0.00308	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000191	0.00308	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—APOA1—stomach cancer	0.000188	0.00302	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000188	0.00302	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—stomach cancer	0.000188	0.00302	CbGpPWpGaD
Nepafenac—Pruritus—Epirubicin—stomach cancer	0.000187	0.0015	CcSEcCtD
Nepafenac—Dizziness—Methotrexate—stomach cancer	0.000187	0.0015	CcSEcCtD
Nepafenac—PTGS1—Biological oxidations—GSTP1—stomach cancer	0.000185	0.00298	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—stomach cancer	0.000185	0.00297	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000183	0.00294	CbGpPWpGaD
Nepafenac—Hypersensitivity—Doxorubicin—stomach cancer	0.00018	0.00144	CcSEcCtD
Nepafenac—Vomiting—Methotrexate—stomach cancer	0.00018	0.00144	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000179	0.00288	CbGpPWpGaD
Nepafenac—Headache—Methotrexate—stomach cancer	0.000177	0.00142	CcSEcCtD
Nepafenac—Dizziness—Epirubicin—stomach cancer	0.000175	0.0014	CcSEcCtD
Nepafenac—Pruritus—Doxorubicin—stomach cancer	0.000173	0.00139	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	0.000172	0.00277	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.000171	0.00275	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTM1—stomach cancer	0.00017	0.00274	CbGpPWpGaD
Nepafenac—Vomiting—Epirubicin—stomach cancer	0.000168	0.00135	CcSEcCtD
Nepafenac—Nausea—Methotrexate—stomach cancer	0.000168	0.00134	CcSEcCtD
Nepafenac—Headache—Epirubicin—stomach cancer	0.000166	0.00133	CcSEcCtD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—stomach cancer	0.000164	0.00264	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—stomach cancer	0.000162	0.00261	CbGpPWpGaD
Nepafenac—Dizziness—Doxorubicin—stomach cancer	0.000162	0.0013	CcSEcCtD
Nepafenac—PTGS1—Metabolism—ACAD8—stomach cancer	0.000159	0.00256	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	0.000159	0.00255	CbGpPWpGaD
Nepafenac—Nausea—Epirubicin—stomach cancer	0.000157	0.00126	CcSEcCtD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000156	0.00251	CbGpPWpGaD
Nepafenac—Vomiting—Doxorubicin—stomach cancer	0.000156	0.00125	CcSEcCtD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000156	0.0025	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000155	0.0025	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000155	0.0025	CbGpPWpGaD
Nepafenac—Headache—Doxorubicin—stomach cancer	0.000153	0.00123	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000153	0.00247	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—stomach cancer	0.000153	0.00246	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000149	0.0024	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—stomach cancer	0.000149	0.0024	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000148	0.00238	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000147	0.00236	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000146	0.00235	CbGpPWpGaD
Nepafenac—Nausea—Doxorubicin—stomach cancer	0.000146	0.00116	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN2A—stomach cancer	0.000145	0.00233	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDK4—stomach cancer	0.000144	0.00232	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GMPR2—stomach cancer	0.000142	0.00228	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—stomach cancer	0.000138	0.00222	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000137	0.00221	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000135	0.00218	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.00013	0.00209	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SUCLG1—stomach cancer	0.00013	0.00209	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—IDH3B—stomach cancer	0.00013	0.00209	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN1B—stomach cancer	0.000128	0.00206	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.000128	0.00206	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACAD8—stomach cancer	0.000126	0.00203	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000126	0.00202	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	0.000125	0.002	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000124	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CCND1—stomach cancer	0.000122	0.00197	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—stomach cancer	0.000121	0.00195	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NDUFV1—stomach cancer	0.000121	0.00194	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NDUFS1—stomach cancer	0.000121	0.00194	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN1A—stomach cancer	0.000118	0.0019	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000118	0.0019	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000116	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—RHOA—stomach cancer	0.000114	0.00183	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GMPR2—stomach cancer	0.000113	0.00181	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—stomach cancer	0.000111	0.00178	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000109	0.00175	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PGLS—stomach cancer	0.000108	0.00173	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BLVRB—stomach cancer	0.000108	0.00173	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000108	0.00173	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—IDH3B—stomach cancer	0.000103	0.00166	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SUCLG1—stomach cancer	0.000103	0.00166	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPAP2A—stomach cancer	0.000103	0.00165	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PGLS—stomach cancer	0.000102	0.00164	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—stomach cancer	9.99e-05	0.00161	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	9.87e-05	0.00159	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	9.81e-05	0.00158	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—MYC—stomach cancer	9.8e-05	0.00158	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDKN1B—stomach cancer	9.76e-05	0.00157	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RBP1—stomach cancer	9.73e-05	0.00157	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—stomach cancer	9.58e-05	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NDUFS1—stomach cancer	9.58e-05	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NDUFV1—stomach cancer	9.58e-05	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	9.37e-05	0.00151	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	9.31e-05	0.0015	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	9.23e-05	0.00148	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CA1—stomach cancer	9.15e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CKB—stomach cancer	9.15e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FBP1—stomach cancer	9.15e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NDUFA2—stomach cancer	9.15e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	9.05e-05	0.00146	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	9.04e-05	0.00145	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—stomach cancer	8.94e-05	0.00144	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	8.79e-05	0.00141	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FBP1—stomach cancer	8.67e-05	0.0014	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLIN2—stomach cancer	8.6e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	8.6e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PGLS—stomach cancer	8.54e-05	0.00137	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BLVRB—stomach cancer	8.54e-05	0.00137	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CA2—stomach cancer	8.37e-05	0.00135	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PGAM1—stomach cancer	8.16e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NT5E—stomach cancer	8.16e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPAP2A—stomach cancer	8.15e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	7.84e-05	0.00126	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDH7A1—stomach cancer	7.78e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLCE1—stomach cancer	7.78e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PGAM1—stomach cancer	7.73e-05	0.00124	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	7.7e-05	0.00124	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	7.68e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MYC—stomach cancer	7.47e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—UMPS—stomach cancer	7.46e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS2—Disease—WIF1—stomach cancer	7.37e-05	0.00119	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	7.3e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	7.3e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CKB—stomach cancer	7.26e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CA1—stomach cancer	7.26e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FBP1—stomach cancer	7.26e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NDUFA2—stomach cancer	7.26e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	7.17e-05	0.00115	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	7.1e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—stomach cancer	6.95e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PDHA1—stomach cancer	6.93e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ECHS1—stomach cancer	6.93e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPL13—stomach cancer	6.93e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPL18—stomach cancer	6.93e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLIN2—stomach cancer	6.83e-05	0.0011	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CA2—stomach cancer	6.64e-05	0.00107	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	6.64e-05	0.00107	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RNF43—stomach cancer	6.57e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TYMP—stomach cancer	6.52e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FADS1—stomach cancer	6.52e-05	0.00105	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PGAM1—stomach cancer	6.47e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NT5E—stomach cancer	6.47e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS21—stomach cancer	6.47e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS15—stomach cancer	6.47e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	6.33e-05	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	6.32e-05	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDH7A1—stomach cancer	6.18e-05	0.000994	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLCE1—stomach cancer	6.18e-05	0.000994	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TP53—stomach cancer	6.13e-05	0.000986	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	6.13e-05	0.000985	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SREBF2—stomach cancer	6.1e-05	0.000982	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—RORA—stomach cancer	6.03e-05	0.00097	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.98e-05	0.000962	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UMPS—stomach cancer	5.92e-05	0.000953	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDOB—stomach cancer	5.65e-05	0.000909	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—stomach cancer	5.61e-05	0.000903	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	5.52e-05	0.000888	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PDHA1—stomach cancer	5.5e-05	0.000886	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ECHS1—stomach cancer	5.5e-05	0.000886	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ALDOB—stomach cancer	5.36e-05	0.000862	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.33e-05	0.000857	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.32e-05	0.000856	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX5—stomach cancer	5.26e-05	0.000845	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPL15—stomach cancer	5.25e-05	0.000845	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	5.22e-05	0.00084	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FADS1—stomach cancer	5.18e-05	0.000833	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TYMP—stomach cancer	5.18e-05	0.000833	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DPYD—stomach cancer	5.17e-05	0.000832	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NPM1—stomach cancer	5.16e-05	0.00083	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	5.08e-05	0.000817	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RBP4—stomach cancer	4.98e-05	0.000801	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.97e-05	0.000799	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.97e-05	0.000799	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS26—stomach cancer	4.9e-05	0.000788	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPIA—stomach cancer	4.86e-05	0.000782	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SREBF2—stomach cancer	4.85e-05	0.00078	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—RORA—stomach cancer	4.79e-05	0.00077	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.73e-05	0.000761	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.69e-05	0.000755	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.69e-05	0.000754	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTT1—stomach cancer	4.57e-05	0.000735	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2A6—stomach cancer	4.52e-05	0.000727	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDOB—stomach cancer	4.49e-05	0.000722	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKR1C3—stomach cancer	4.4e-05	0.000707	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.31e-05	0.000694	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ENO1—stomach cancer	4.28e-05	0.000689	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.23e-05	0.000681	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.22e-05	0.000679	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.21e-05	0.000678	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX5—stomach cancer	4.17e-05	0.000671	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	4.17e-05	0.000671	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS19—stomach cancer	4.17e-05	0.00067	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKR1C3—stomach cancer	4.17e-05	0.00067	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DPYD—stomach cancer	4.1e-05	0.00066	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ENO1—stomach cancer	4.06e-05	0.000653	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CD44—stomach cancer	3.8e-05	0.000611	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.72e-05	0.000598	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.69e-05	0.000593	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS6—stomach cancer	3.68e-05	0.000593	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTT1—stomach cancer	3.63e-05	0.000584	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD44—stomach cancer	3.6e-05	0.000579	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2A6—stomach cancer	3.59e-05	0.000577	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKR1C3—stomach cancer	3.49e-05	0.000561	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ENO1—stomach cancer	3.4e-05	0.000547	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HBEGF—stomach cancer	3.39e-05	0.000545	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.34e-05	0.000538	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPP2R1A—stomach cancer	3.23e-05	0.00052	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTP1—stomach cancer	3.17e-05	0.00051	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—stomach cancer	3.13e-05	0.000503	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPP2R1A—stomach cancer	3.06e-05	0.000493	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CD44—stomach cancer	3.02e-05	0.000485	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TYMS—stomach cancer	2.95e-05	0.000474	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM1—stomach cancer	2.91e-05	0.000468	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SMAD4—stomach cancer	2.84e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ERCC2—stomach cancer	2.74e-05	0.00044	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FYN—stomach cancer	2.7e-05	0.000434	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERCC2—stomach cancer	2.6e-05	0.000417	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—stomach cancer	2.57e-05	0.000414	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPP2R1A—stomach cancer	2.56e-05	0.000413	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGFR2—stomach cancer	2.53e-05	0.000408	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTP1—stomach cancer	2.52e-05	0.000405	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—stomach cancer	2.48e-05	0.000399	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—stomach cancer	2.44e-05	0.000392	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAV1—stomach cancer	2.37e-05	0.000382	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA1—stomach cancer	2.37e-05	0.000381	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TYMS—stomach cancer	2.34e-05	0.000376	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS2—stomach cancer	2.32e-05	0.000373	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM1—stomach cancer	2.31e-05	0.000372	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.27e-05	0.000365	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CAV1—stomach cancer	2.25e-05	0.000362	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA1—stomach cancer	2.25e-05	0.000361	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ERCC2—stomach cancer	2.17e-05	0.00035	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6ST—stomach cancer	2.13e-05	0.000343	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—stomach cancer	2.09e-05	0.000336	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APC—stomach cancer	2.05e-05	0.00033	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—stomach cancer	2.04e-05	0.000329	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6R—stomach cancer	1.9e-05	0.000306	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAV1—stomach cancer	1.88e-05	0.000303	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA1—stomach cancer	1.88e-05	0.000302	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—stomach cancer	1.88e-05	0.000302	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.8e-05	0.00029	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—stomach cancer	1.79e-05	0.000289	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—stomach cancer	1.78e-05	0.000287	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RHOA—stomach cancer	1.72e-05	0.000277	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—stomach cancer	1.7e-05	0.000274	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—stomach cancer	1.66e-05	0.000267	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—stomach cancer	1.64e-05	0.000264	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERBB2—stomach cancer	1.59e-05	0.000256	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—stomach cancer	1.49e-05	0.00024	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1B—stomach cancer	1.47e-05	0.000237	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—stomach cancer	1.42e-05	0.000229	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1A—stomach cancer	1.36e-05	0.000219	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT3—stomach cancer	1.21e-05	0.000195	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK3—stomach cancer	1.16e-05	0.000187	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MYC—stomach cancer	1.13e-05	0.000181	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK1—stomach cancer	1.1e-05	0.000177	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGFR—stomach cancer	1.1e-05	0.000177	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KRAS—stomach cancer	1.04e-05	0.000168	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CA—stomach cancer	1.01e-05	0.000162	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CA—stomach cancer	9.57e-06	0.000154	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HRAS—stomach cancer	8.86e-06	0.000142	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—stomach cancer	8.48e-06	0.000136	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CA—stomach cancer	8.02e-06	0.000129	CbGpPWpGaD
